X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (13) 13
index medicus (12) 12
compositions based thereon (11) 11
female (11) 11
humans (11) 11
macromolecular compounds obtained otherwise than by reactionsonly involving unsaturated carbon-to-carbon bonds (11) 11
metallurgy (11) 11
organic macromolecular compounds (11) 11
their preparation or chemical working-up (11) 11
male (9) 9
adult (7) 7
melanoma (7) 7
oncology (7) 7
guidelines (6) 6
after-treatment not covered by subclasses c08b, c08c, c08f,c08g (5) 5
aged (5) 5
article (5) 5
general processes of compounding (5) 5
middle aged (5) 5
working-up (5) 5
animals (4) 4
kaplan-meier estimate (4) 4
melanoma - drug therapy (4) 4
abridged index medicus (3) 3
analysis (3) 3
antibodies, monoclonal - adverse effects (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antineoplastic agents - therapeutic use (3) 3
b7 family (3) 3
cancer (3) 3
character education (3) 3
drug therapy (3) 3
gene expression (3) 3
immunotherapy (3) 3
medicine, general & internal (3) 3
solid tumors (3) 3
016:17 (2) 2
016:37.013.01 (2) 2
17:016 (2) 2
acrolein (2) 2
aged, 80 and over (2) 2
aldehydes (2) 2
antineoplastic agents - adverse effects (2) 2
b7-h1 (2) 2
bibliographie (2) 2
bibliography (2) 2
biomass (2) 2
biotechnology (2) 2
blockade (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
catalysts (2) 2
cell lung-cancer (2) 2
chemistry, applied (2) 2
colony-stimulating factor (2) 2
colorectal neoplasms - drug therapy (2) 2
compositions of macromolecular compounds (2) 2
dehydration (2) 2
disease models, animal (2) 2
disease-free survival (2) 2
docetaxel (2) 2
dosage and administration (2) 2
drugs (2) 2
développement moral (2) 2
early detection (2) 2
ethical development (2) 2
ethical education (2) 2
ethische vorming (2) 2
glycerol (2) 2
gm-csf (2) 2
granulocyte-macrophage colony-stimulating factor - administration & dosage (2) 2
immune response (2) 2
industrial chemistry/chemical engineering (2) 2
investigations (2) 2
ipilimumab (2) 2
keratinocyte carcinoma (2) 2
medicine & public health (2) 2
melanoma odds ratio (2) 2
melanoma relative risk (2) 2
melanoma risk factors (2) 2
moral development (2) 2
moral development -- bibliography (2) 2
moral development bibliography (2) 2
moral education (2) 2
moral education - bibliographies (2) 2
moral education -- bibliography (2) 2
moral education bibliography (2) 2
neoplasm metastasis (2) 2
original reports (2) 2
patients (2) 2
programmed cell death 1 receptor - metabolism (2) 2
prostate (2) 2
research (2) 2
responses (2) 2
screening (2) 2
sittliche erziehung (2) 2
skin cancer (2) 2
skin neoplasms - drug therapy (2) 2
sulfuric acid (2) 2
supercritical water (2) 2
survival (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e14539 - e14539
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 26, pp. 2443 - 2454
Releasing T cells from inhibitory control has been a strategy exploited by the anti–CTLA-4 antibody ipilimumab. Now an antibody against a second checkpoint... 
CELL LUNG-CANCER | MEDICINE, GENERAL & INTERNAL | THERAPY | SOLID TUMORS | RESPONSE CRITERIA | IMMUNOTHERAPY | GUIDELINES | B7 FAMILY | B7-H1 | ANTITUMOR IMMUNITY | BLOCKADE | Neoplasms - metabolism | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - metabolism | Antibodies, Monoclonal - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Neoplasms - drug therapy | Dose-Response Relationship, Drug | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Melanoma - drug therapy | Adult | Female | Ligands | Antineoplastic Agents - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - immunology | Carcinoma, Renal Cell - drug therapy | Prostatic Neoplasms - drug therapy | Drugs | Dose-response relationship (Biochemistry) | Immune response | Anti-antibodies | Dosage and administration | Product/Service Evaluations | Regulation | Research | Drug therapy | Cancer | Fees & charges | Kidneys | Stock options | PD-1 protein | Laboratories | Toxicity | Tumor cells | Body weight | Lung cancer | Colorectal carcinoma | Colorectal cancer | Melanoma | Licenses | Lymphocytes T | Patients | Castration | PD-L1 protein | Antitumor activity | Prostate cancer | Drug dosages | Prostate | Clear cell-type renal cell carcinoma | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 10, pp. 1020 - 1030
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e20105 - e20105
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 18_suppl, pp. CRA9007 - CRA9007
Journal Article
Melanoma management, ISSN 2045-0885, 03/2017, Volume 4, Issue 1, pp. 13 - 37
Melanoma is usually apparent on the skin and readily detected by trained medical providers using a routine total body skin examination, yet this malignancy is... 
Task forces | Disease | Mortality | Melanoma | Medical screening | Patients | Epidemiology | Primary care | Risk factors | Morbidity | Defects | Skin cancer | Family physicians | International organizations | Disease prevention | Surveillance | Trends | Age | USPSTF | skin cancer | melanoma odds ratio | screening | melanoma risk factors | guidelines | melanoma | early detection | keratinocyte carcinoma | melanoma relative risk
Journal Article
Oncology Reviews, ISSN 1970-5557, 12/2011, Volume 4, Issue 3
Journal Article
Oncology Reviews, ISSN 1970-5557, 12/2011, Volume 4, Issue 3, p. 147
This study systematically reviews outcomes after inferior vena cava (IVC) filtration in cancer-associated venous thromboembolism (VTE). A comprehensive review... 
IVC filter - Cancer - Review - Thromboembolism
Journal Article
Oncology Reviews, ISSN 1970-5557, 9/2010, Volume 4, Issue 3, pp. 147 - 157
This study systematically reviews outcomes after inferior vena cava (IVC) filtration in cancer-associated venous thromboembolism (VTE). A comprehensive review... 
Oncology | Review | Medicine & Public Health | Thromboembolism | IVC filter | Cancer | Pulmonary embolism | Anticoagulants (Medicine) | Research | Oncology, Experimental
Journal Article
Melanoma Management, ISSN 2045-0885, 03/2017, Volume 4, Issue 1, pp. 13 - 37
Melanoma is usually apparent on the skin and readily detected by trained medical providers using a routine total body skin examination, yet this malignancy is... 
USPSTF | skin cancer | melanoma odds ratio | screening | melanoma risk factors | guidelines | melanoma | early detection | keratinocyte carcinoma | melanoma relative risk
Journal Article
JAMA oncology, ISSN 2374-2437, 07/2019, Volume 5, Issue 10, p. 1411
Nivolumab, a monoclonal antibody that inhibits programmed cell death 1, is approved by the US Food and Drug Administration for treating advanced melanoma,... 
Index Medicus
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 09/1994, Volume 33, Issue 5, pp. 415 - 419
The use of mitomycin for metastatic colorectal cancer has been limited by mitomycin's myelosuppressive potential. The objective of this randomized study was to... 
CONTINUOUS INFUSION FLUOROURACIL | ONCOLOGY | PHARMACOLOGY & PHARMACY | Mitomycin - adverse effects | Bone Marrow Diseases - chemically induced | Mitomycin - therapeutic use | Colorectal Neoplasms - drug therapy | Humans | Middle Aged | Adult | Amifostine - therapeutic use | Female | Male | Aged | Bone Marrow Diseases - prevention & control
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 02/1994, Volume 33, Issue 5, pp. 415 - 419
Journal Article
Cancer, ISSN 0008-543X, 12/1984, Volume 54, Issue 12, pp. 3043 - 3047
An atypical presentation of herpes simplex virus type 1 (HSV‐I) in the form of nodular tongue lesions was documented by histologic and immunohistochemical... 
Tongue Diseases - etiology | Hodgkin Disease - pathology | Humans | Adult | Female | Stomatitis, Herpetic - pathology | Tongue - pathology | Hodgkin Disease - complications | Stomatitis, Herpetic - etiology
Journal Article
Cancer Investigation, ISSN 0735-7907, 1988, Volume 6, Issue 3, pp. 267 - 270
Journal Article